Condition
Mitral Annular Calcification
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed2
Unknown1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04408430Not ApplicableRecruitingPrimary
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
NCT02830204Not ApplicableCompletedPrimary
Surgical Implantation of TRAnscatheter vaLve in Native Mitral Annular Calcification (SITRAL) Study
NCT03539458Not ApplicableCompleted
Feasibility Study of the Tendyne Mitral Valve System in Mitral Annular Calcification
NCT04429035Not ApplicableUnknown
SLOW-Slower Progress of caLcificatiOn With Vitamin K2
Showing all 4 trials